Menu
Recruiting NCT07302204

Efficacy of Aerobic Exercise Versus Therapeutic Exercises on Exercise-induced Hypoalgesia in Knee Osteoarthritis

No phase Interventional Osteoarthritis of the Knee

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Aerobic Exercise, Therapeutic Exercise.
Who it may be relevant to
Registry conditions: Osteoarthritis of the Knee. Basic parameters: 40 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Brazil
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Efficacy of Aerobic Exercise Versus Therapeutic Exercises on Exercise-induced Hypoalgesia in Knee Osteoarthritis. Randomized Clinical Trial

Overview

The study compares two exercise strategies in people with knee osteoarthritis. The first is aerobic exercise on a recumbent cycle ergometer, with effort controlled by the Borg scale. The second is a therapeutic exercise program with resistance, neuromuscular, mobility, and balance components. The primary objective is to determine which approach produces greater exercise induced hypoalgesia, measured by the increase in pressure pain threshold at the knee within the session across four anchor sessions during a ten week program. This is a randomized clinical trial with two parallel arms. Ninety participants, between forty five and seventy five years of age, will be allocated to one of the two groups. Allocation sequence concealment will be ensured using opaque envelopes. The outcome assessor will remain blinded to group allocation. The interventions will take place three times per week for ten weeks. Assessments will be performed at baseline and after ten weeks. Within session measurements will also be taken in weeks one, four, seven, and ten. The primary outcome is the intra session change in pressure pain threshold at the medial compartment of the knee. Secondary outcomes include exercise induced hypoalgesia in the quadriceps and trapezius, chronic adaptation of pressure pain threshold, conditioned pain modulation, pain intensity, pain self efficacy, knee related health status, functional performance, quadriceps strength, global perceived effect, and adherence. The planned sample size is forty five participants per group. The analysis will follow the intention to treat principle. The primary outcome will be compared using linear mixed models with group and time effects. Clinical outcomes at T1 will be adjusted for baseline values. Estimates, confidence intervals, and interpretation in light of minimally important differences will be reported.

Interventions

  • Other Aerobic Exercise
    Supervised cycling on an electromagnetic recumbent stationary bicycle three times per week for ten weeks, with at least 24 hours between sessions.
  • Other Therapeutic Exercise
    Individually supervised, land based therapeutic exercise program focusing on warm up, resisted strengthening, neuromuscular training, mobility and balance.

Primary outcome measures

  • Exercise-induced hypoalgesia (EIH) [Time frame: At weeks 1, 4, 7, and 10 of the 10 week intervention (within session, pre and immediately post exercise).]
Secondary outcome measures (12)
  • Exercise induced hypoalgesia of the quadriceps [Time frame: Within session, immediately before and immediately after the exercise session at weeks 1, 4, 7, and 10 of the 10 week intervention.]
  • Exercise induced hypoalgesia of the upper trapezius [Time frame: Within session, immediately before and immediately after the exercise session at weeks 1, 4, 7, and 10 of the 10 week intervention.]
  • Chronic adaptation of pressure pain threshold [Time frame: Baseline and after 10 weeks of intervention.]
  • Conditioned pain modulation [Time frame: Baseline and after 10 weeks of intervention.]
  • Pain intensity [Time frame: Baseline and after 10 weeks of intervention.]
  • Pain self efficacy [Time frame: Baseline and after 10 weeks of intervention.]
  • Knee related health status [Time frame: Baseline and after 10 weeks of intervention.]
  • Patient specific functional status [Time frame: Baseline and after 10 weeks of intervention.]
  • Functional performance, thirty second sit to stand test [Time frame: Baseline and after 10 weeks of intervention.]
  • Quadriceps muscle strength [Time frame: Baseline and after 10 weeks of intervention.]
  • Global perceived effect [Time frame: After 10 weeks of intervention.]
  • Adherence to the intervention [Time frame: Throughout the 10 week intervention period.]

Eligibility criteria

Inclusion criteria

  • Clinical diagnosis of symptomatic knee osteoarthritis for at least 3 months.
  • Report of knee pain for more than 3 months and average knee pain intensity ≥ 3 on the 0 to 10 Numeric Rating Scale.
  • Morning stiffness lasting less than 30 minutes.
  • Clinical signs compatible with knee osteoarthritis. crepitus, bony tenderness and absence of palpable warmth at the knee.
  • Altered exercise-induced hypoalgesia: absence of exercise-induced hypoalgesia and hyperalgesic response to exercise.

Exclusion criteria

  • Signs and symptoms indicating the hip as the main source of pain.
  • Osteoporosis
  • Fibromyalgia
  • History of tumors or cancer
  • Active inflammatory joint diseases, such as rheumatoid arthritis or gout.
  • Previous arthroplasty of any lower limb joint.
  • Neurological diseases, including Parkinson's disease, stroke, multiple sclerosis, muscular dystrophy, motor neuron disease or Alzheimer's disease.
  • Cardiovascular diseases for which exercise is formally contraindicated.
  • Infected wounds or osteomyelitis in the knee region.
  • Deep vein thrombosis or thrombophlebitis.
  • Sensory alterations in the lower limbs.
  • Cognitive or cardiopulmonary impairments that limit safe participation in the exercise program.
  • Use of walking aids.
  • Recent knee trauma.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Brazil · 2 centers
  • Cid André Fidelis de Paula Gomes — São Paulo
  • Nove de Julho University — São Paulo

Identifiers

NCT: NCT07302204 · 93560425.7.0000.5511

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗